Injectable Microspheres and Liposomes
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
303
NCT00128531
Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer
Phase: Phase 3
Role: Lead Sponsor
Start: Sep 30, 2005
Completion: Nov 30, 2007
NCT00630799
Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients
Start: May 31, 2008
Completion: Jul 31, 2009
NCT01415960
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Start: Sep 30, 2011
Completion: Nov 30, 2013
Loading map...